Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
Subline B16-F10, a variant cell line of B16 melanoma, is highly metastatic to the lung when injected intravenously into C57BL/6 mice. This experimental metastasis model was used to test the anti-tumor effect of exogenous RNA extracted from the lymphoid organs of immunized animals with B16-F10 cells. This RNA preparation is referred to as B16-RNA. Adoptive immunotherapy with lymphocytes treated with B16-RNA was effective in reducing significantly the number of pulmonary metastatic nodules. Lymphocytes incubated with medium alone or with RNA from non-immunized animals (N-RNA) were used as controls. The ability of B16-RNA in modulating antimetastatic activity of normal lymphocytes is abolished by hydrolysis with KOH. This finding indicates that the integrity of the polynucleotide chain is essential for the activity of B16-RNA. The anti-tumor effect of lymphocytes treated with B16-RNA was enhanced by incubation with a low dose of interleukin-2 (IL-2). A possible role of the double-stranded RNA dependent protein kinase in this phenomenon is discussed.
Watanabe
M A
MA
Department of Biochemistry, School of Medicine, University of São Paulo, Ribeirão Preto, Brazil.
Almeida
D O
DO
Serrano
S V
SV
Sales
V S
VS
Soares
F A
FA
de Lucca
F L
FL
D000818:Animals; D006168:Guinea Pigs; D007111:Immunity, Cellular; D007114:Immunization; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007376:Interleukin-2 / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy; D008214:Lymphocytes / Q000276:immunology*; D008546:Melanoma, Experimental / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D012334:RNA, Neoplasm / Q000008:administration & dosage / Q000276:immunology*
D007376:Interleukin-2; D012334:RNA, Neoplasm